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Chimerism is a phenomenon in which an individual has 
cells with different genetic content from different zygotes. In 
dizygotic twins (DTs), chimerism is believed to occur through 
placental anastomoses that enable the bidirectional exchange of 
hematopoietic stem cells. Little is still known about chimerism 
frequency in twins, but several studies have shown a relation 
between chimerism and some conditions such as autism, 
Alzheimer’s disease, and a group of autoimmune diseases such 
as Sjögren syndrome, systemic lupus erythematosus, and 
systemic sclerosis. In addition to chimerism of ABO blood groups 
being possibly mistaken for ABO subgroups, these autoimmune 
diseases may affect other serologic immunohematologic tests. 
This study aimed to determine the frequency of chimerism in 
DTs through ABO and D testing using the tube method, column 
agglutination, and short tandem repeat (STR) assays. Among the 
103 subjects assessed for this study, 24 subjects (12 pairs) were 
excluded because STR assays showed they were monozygotic; of 
the remaining, 70 subjects (35 pairs) were DTs and 9 subjects came 
from gestations of trizygotic triplets. No ABO or D chimerism 
was detected in any subject through serologic assays, and STR 
assays did not detect any blood chimerism. Although there was 
no evidence of chimerism found in this study, we emphasize the 
importance of observing the family background of individuals 
with suspected ABO subgroup in complex immunohematologic 
studies because ABO antigen–antibody reactions are similar in 
both circumstances, and chimerism can be overlooked. Moreover, 
the use of the STR analysis method in chimerism studies can be 
important to help differentiate chimerism and ABO subgroups. 
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The term chimerism refers to an organism formed by 
two or more genomes from different embryos. When these 
cells are present in a small percentage (≤10%), the term 
microchimerism is used.1,2
Chimerism may occur during the development of 
dichorionic dizygotic twins (DTs), since the proximity of the 
placentas may lead to the formation of placental anastomoses or 
monochorionic DTs through the formation of a monochorionic 
placenta.3,4 With the formation of anastomoses occurs the 
exchange of hematopoietic stem cells between the fetuses, 
which, through tropism, nidation, and proliferation, become 
permanent in the bone marrow and begin to produce cells of 
the donor twin throughout life. In this way, chimeric twins 
may present two different phenotypes for the same blood 
group system antigens. This dual phenotypic expression 
occurs once the exchange of hematopoietic stem cells takes 
place and before the development of the fetal immune system: 
it creates a constant state of immunologic tolerance so both 
of the phenotypes are expressed on the erythrocyte surface of 
the adult individuals. Thus, the twins develop as chimeras—
namely, individuals with different genetic origin cells that 
coexist and have a different phenotypic expression for the 
same blood group system antigens.2,3,5,6
Chimerism has been associated with the appearance 
of autoimmune diseases in post-pregnant women and in 
patients after bone marrow transplant and non-isogroup 
blood transfusions. In twins, microchimerism has been 
associated with the premature and more frequent appearance 
of Alzheimer’s disease.5,6
Currently, several procedures or cell culture conditions 
used in in vitro fertilization/embryo transfer (IVF-ET) may 
lead to changes in cell-surface nature and increase the risk 
of cell fusion. Such data are important because, regardless 
of the germinative heritage of the twins, the monochorionic 
placenta increases the probability of the formation of vascular 
connections between the two fetal circulations.3,7–9
Within transfusion medicine, chimerism and micro-
chimerism may also occur through non-isogroup blood 
transfusion, organ transplantation, allogeneic stem cell 
transplantation,10 and transit of cells between mother and child 
(fetal–maternal) during gestation.3 Chimerism may also cause 
immune hemolytic transfusion reactions in recipients; thus, 
preemptive detection is important.11,12 Moreover, individuals 
with blood group chimerism (BGC) may be wrongly classified 
as ABO blood subgroups.13–15
Chimerism may also be assessed in nucleated cells 
through genetic analysis of short tandem repeats (STRs). In 
red blood cells (RBCs), chimerism can be assessed by flow 
cytometry that is sensitive enough to detect one RBC with a 
specific antigen among 10,000 RBCs without this antigen. The 
method of assessing chimerism by STR analysis of peripheral 
blood is considered the gold standard and is already used to 
detect chimerism in cases of bone marrow transplant.16
This study aimed to assess the frequency of ABO 
and D antigens using both immunohematologic methods 
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and STR analysis because BGC may cause transfusion 
reactions or be mistaken for ABO subgroups in phenotypic 
immunohematologic assays.
Materials and Methods
After approval by the human research ethics committee, 
peripheral blood was collected from 50 DTs and/or trizygotic 
triplets (TTs) from the state of Santa Catarina, Brazil, between 
May and September 2017. The exclusion criteria restricted 
pregnant women who had given birth or had had a miscarriage 
in the previous 120 days, individuals who had received a blood 
transfusion in the previous 120 days, and individuals who had 
had organ and/or bone marrow transplantation. The selection 
of the 50 DTs and TTs used criteria of age (between 1 and 65 
years), including six pairs of twins over 18 years of age, and 
having a non-identical twin brother or sister confirmed by 
STR assay, so that monozygotic twins were not included in the 
research.
Immunohematologic assays were performed to determine 
ABO blood group and D antigen status through tube methods 
using monoclonal sera and reagent RBCs (DiaClon ABO/D 
reagent and DiaCell ABO Reverse Grouping Cells, Bio-Rad 
Laboratories, Hercules, CA). The results were interpreted 
according to Girello and Kuhn.17 The same ABO and D testing 
was carried out in a column agglutination system (BioVue 
Anti-A,-B,-D Card and Affirmagen Reverse Grouping Cells; 
Ortho Clinical Diagnostics, Raritan, NJ), and the tests were 
interpreted according to the manufacturer’s directions.18
The presence of chimerism among the DTs and TTs 
was assessed using STR genotyping at the Clinics Hospital 
of Porto Alegre in the state of Rio Grande do Sul, Brazil. 
The samples were amplified by multiplex polymerase chain 
reaction, and 16 STR loci were amplified: amelogenin, vWA, 
D7S820, FGA, LPL, TH01, D12S391, D16S539, D3S1358, 
D8S1179, TPOX, CSF1PO, Penta D, D13S317, D18S51, and 
Penta E. The fluorescent dyes (VIC, FAM, PET, and NED; 
Standard Dye Kit, Applied Biosystems, Foster City, CA) were 
used to stain the primers. An internal standard (GeneScan 
500 LIZ, Thermo Fisher Scientific, Waltham, MA) was used 
for capillary electrophoresis, carried out in a sequencer (ABI 
3500xL, Thermo Fisher Scientific). The results were analyzed 
using software (GeneMapper, version 4.1., Thermo Fisher 
Scientific). This method was carried out according to the 
fundamentals described in the literature,19,20 and this method 
was previously adapted and standardized by the laboratory 
(results not published in scientific papers).
Results
After application of the exclusion criteria, 12 DTs (24 
individuals) were excluded because STR analysis showed they 
were monozygotic. These twins were completely identical in 
16 loci analyzed and had the same ABO blood group and D 
status. Consequently, 79 subjects remained in the study group, 
70 of whom were DTs (35 pairs) and 9 of whom were from TT 
gestations (Tables 1 and 2).
No BGC could be found among the twins in this study 
using immunohematologic methods. STR analysis was 
performed even for the subjects with the same ABO and/or D 
classification to investigate the possible presence of chimerism.
When assessing chimerism through STR sequencing, a 
mixture of DNA is sought (that is, two genetic profiles in the 
same sample). The STRs are noncoding regions of DNA—in 
other words, they are not gene regions—and they are often 
used in paternity testing and criminal investigations because 
of their high polymorphism among populations. Not all the 
analyzed loci are informative. A locus is considered informative 
when at least one allele of each individual is not shared. In 
the case of siblings, many loci are going to be considered 
equal or to have shared alleles; therefore, a minor number of 
informative loci are expected when compared with nonrelated 
individuals. In informative loci, it is necessary to verify the 
presence of unshared alleles of a twin in the other, meaning 
that, in the case of chimerism, this testing would result in the 
amplification of three or four alleles in the informative loci. 
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Table 1. Gender and age of study subjects
Number of 
subjects Age, years Females Males
All subjects 79  29 ± 14 43 36
Dizygotic twins 70  30 ± 16 37 33
Trizygotic triplets 9  27 ± 5 6 3









ABO = ABO 
RhD ≠ RhD
N (%)
ABO = ABO 
RhD = RhD
Dizygotic twins 1 (2.9) 7 (20.0) 4 (11.4) 23 (65.7)
Trizygotic triplets NR 1 (33.3) NR 2 (66.6)
≠, Immunohematology results differed; =, Immunohematology results were 
the same; NR = no result found.
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Fig. 1 Electropherogram of the short tandem repeat (STR) analysis results for loci LPL, TH01, D12S391, and D16S639 in twin 0001 and 
twin 0002. The y axis represents the number of relative fluorescence units (RFUs), and the x axis represents the base pairs. This information 
is a semiquantitative measure, not quantitative. The threshold used was 50 RFUs.
Fig. 2 Electropherogram of the short tandem repeat (STR) analysis results for loci Vwa, D7S820, and FGA in twin 0001 and twin 0002. 
The y axis represents the number of relative fluorescence units (RFUs), and the x axis represents the base pairs. This information is a 
semiquantitative measure, not quantitative. The threshold used was 50 RFUs.
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Fig. 3 Electropherogram of the short tandem repeat (STR) analysis results for loci D13S317, D18S51, and Penta E in twin 0001 and twin 
0002. The y axis represents the number of relative fluorescence units (RFUs), and the x axis represents the base pairs. This information is a 
semiquantitative measure, not quantitative. The threshold used was 50 RFUs.
Fig. 4 Electropherogram of the short tandem repeat (STR) analysis results for loci D3S1358, D8S1179, TPOX, CSF1PO, and Penta D in 
twin 0001 and twin 0002. The y axis represents the number of relative fluorescence units (RFUs), and the x axis represents the base pairs. 
This information is a semiquantitative measure, not quantitative. The threshold used was 50 RFUs.
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Readers are directed to other specific references about STR 
analysis.21
Figures 1–4 are electropherograms of one pair of studied 
twins, serving as an example. Twins were labeled as 0001 
and 0002. The analyzed loci amelogenin, vWA, LPL, TH01, 
D12S391, D3S1358, D8S1179, TPOX, CSF1PO, D13S317, 
and Penta E are not informative to assess the presence of 
chimerism. For the pair of twins represented in Figures 1–4, 
the informative loci are D7S820, FGA, D16S539, Penta D, 
D8S1179, and D18S51. A figure analysis shows there was no 
amplification of three or more alleles in the informative loci.
All subjects in the research had unique genetic profiles 
with no mixture of genetic material from their respective twin, 
which confirms that there were no two populations of cells 
with distinct genetic characteristics from each other.
Discussion
The increase in the number of twin pregnancies, 
particularly those resulting from IVF-ET, may increase 
chimerism frequency through higher changes of monokaryosis 
occurring in these cases.22 The present research did not assess 
the use of IVF-ET.
In recent decades, the number of couples seeking IVF-
ET has increased due to the global trend of women delaying 
maternity.23,24 The widespread popularity of fertility clinics 
and embryo banks across Brazil resulted in the rate of IVF-ET 
skyrocketing in this country over the last decade, increasing 
the chances of chimerism occurring in multiple gestations. 
Given that the average age of the subjects in this study was 
29 ± 14 years, the number of IVF-ET pregnancies in this group 
is likely not high (although its use was not analyzed), which 
may partially justify the lack of chimerism in the results of this 
study. Prior studies have found around 3 percent of BGC in 
DTs or TTs, whereas, in this study, we found none; hence, our 
hypothesis is based on our participant pool age range.
The subjects in a study by Van Dijk et al.16 were 4 years 
old. In our study, the average age was 29 ± 14 years old, and 
only one DT pair was 6 years old. In adulthood, the proportion 
of two-cell populations may vary; however, the relative 
penetration of such populations into the bone marrow over 
time is unknown. The degree of chimerism in adults could 
decrease or be lost with an increase of age. A limitation in our 
study is the number of participants—our sample size is inferior 
to that of Van Dijk et al.,16 whose study sample included 472 
individuals.
A case of monokaryotic dizygotic twins was mistaken for 
subgroup B3 because of mixed-field reactivity in the column 
agglutination test. After family investigation and STR analysis, 
the case was confirmed as ABO BGC and not subgroup B3.13 In 
the phenotypic immunohematologic laboratory routine of ABO 
classification, chimeric blood may result in a mixed field and 
absence of ABO antibodies, similarly to that seen in an ABO 
subgroup. Therefore, those cases could be mistaken and lead 
to the hypothesis that not all subgroups found in the serologic 
immunohematologic laboratory routine of ABO classification 
are actually subgroups, but are, in some cases, the result of 
a clinical analyst seeing an ABO BGC.14,17,25 Even though 
no evidence of chimerism was detected in this study, it is 
important for professionals who perform immunohematologic 
assays to survey the medical and family background of 
biological samples suspected of being an ABO subgroup to 
correctly diagnose and interpret the blood group in question.
STR analysis was essential to assessing the presence or 
absence of chimerism in the group studied because, among 
the results, 12 pairs of twins expected to be dizygotic were 
shown to be monozygotic. Assessing chimerism through 
STR eliminates the need to test for other blood groups using 
molecular methods (that is, if chimerism is not detected 
through STR, there will be no BGC either). When assessing 
chimerism through STR sequencing, a mixture of DNA is 
sought (that is, two genetic profiles in the same sample).
The frequency of chimerism in twins is not known, but 
better understanding this condition should help medical 
treatment. In recent years, several studies have shown the 
relation between pockets of genetically incompatible cells and 
common conditions such as autism, Alzheimer’s disease,5 and 
a group of autoimmune diseases such as Sjögren syndrome, 
systemic lupus erythematosus, and systemic sclerosis.6 In 
addition to chimerism of ABO blood groups being possibly 
mistaken for ABO subgroups, those autoimmune diseases 
may affect other serologic immunohematologic tests.26
The present study detected no chimerism, but it is 
expected to call more attention to the use of the STR analysis 
method to help differentiate between the BGC and ABO 
subgroup. Additionally, even though in this study chimerism 
was seen as a relatively rare event, it could be considered as a 
possible cause of difficulties in ABO phenotyping once more 
common causes are excluded, such as ABO subgroups, since 
not detecting chimerism could lead to immune hemolytic 
transfusion reactions in cases of chimeric packed RBCs being 
transfused.27
156 IMMUNOHEMATOLOGY, Volume 34, Number 4, 2018
 8. Assaf AS, Randolph LM, Benirschke K, Wu S, Samadi 
R, Chmait RH. Discordant blood chimerism in dizygotic 
monochorionic laser-treated twin-twin transfusion syndrome. 
Obstet Gynecol 2010;116:483–5.
 9. Williams CA, Wallace MR, Drury KC, et al. Blood lymphocyte 
chimerism associated with IVF and monochorionic dizygous 
twinning: case report. Hum Reprod 2004;19:2816–21.
 10. Stahl T, Bohme UM, Kroger N, Fehse B. Digital PCR to 
assess hematopoietic chimerism after allogenic stem cell 
transplantation. Exp Hematol 2015;43:462–8.
 11. Lee T, Paglieroni T, Ohto H, Holland PV, Busch MP. Survival 
of donor leucocyte subpopulations in immunocompetent 
transfusion recipients: frequent long-term microchimerism in 
severe trauma patients. Blood 1999;93:3127–39.
 12. Cho D, Lee SK, Yazer MH, et al. A dispermic chimera with 
mixed field blood group B and mosaic 46,XY/47, XYY 
kariotype. J Korean Med Sci 2007;22:553–6.
 13. Lee O, Cho D, Shin M, et al. The first known case of blood 
group chimerism in monochorionic dizygotic twins in Korea. 
Ann Lab Med 2014;34:259–62.
 14. Bluth MH, Reid ME, Manny N. Chimerism in the 
immunohematology laboratory in the molecular biology era. 
Transfus Med Rev 2007;21:134–46.
 15. Cho D, Lee JS, Yazer MH, et al. Chimerism and mosaicism 
are important causes of ABO phenotype and genotype 
discrepancies. Immunohematology 2006;22:183–7.
 16. Van Dijk BA, Boomsma DI, Man AJM. Blood group chimerism 
in human multiple births is not rare. Am J Med Genet 
1996;61:264–8.
 17. Girello AL, Kuhn TIBB. Fundamentos da imuno-hematologia 
eritrocitária. 4th ed. São Paulo: Senac, 2016.
 18. OrthoWorkstation. Ortho workstation. Available from 
http://www.orthoclinical.com/pt-br/solutions-products/
t r a n s f u s ion -m e d i c i ne/i m mu nohe m ato lo g y/or t ho -
workstation. Accessed 1 December 2016.
L. Tavares et al.
Acknowledgments
The researchers thank Ortho Clinical Diagnostics for 
providing the reagents for the column agglutination technique, 
Unimed Litoral Hospital (Balneário Camboriú, Santa Catarina, 
Brazil) for providing the space and equipment to carry out this 
study, and Batschauer Laboratory for helping to purchase the 
materials for peripheral blood collection. The researchers also 
thank the Clinics Hospital of Porto Alegre for carrying out the 
molecular STR assays.
References
 1. Waszak M, Cieslik K, Wielgus K, et al. Microchimerism in 
twins. Arch Med Sci 2013;9:1102–6.
 2. Chen K, Chmait RH, Vanderbilt D, Wu S, Randolph L. 
Chimerism in monochorionic dizygotic twins: case study and 
review. Am J Med Genet A 2013;161A:1817–24.
 3. Beiguelman B. O estudo de gêmeos. 1st ed. Ribeirão Preto: 
SBG, 2008.
 4. Sharpe C, Lane D, Cote J, et al. Mixed field reactions in 
ABO and Rh typing chimerism likely resulting from twin 
haematopoiesis. Blood Transfus 2014;12:608–10.
 5. Pearson H. Human genetics: dual identities. Nature 
2002;417:10–11.
 6. Ruiz-Arguelles G, Bordes-Aznar J, Díaz-Caballero N, Ruiz-
Delgado G. La importancia del quimerismo en medicina. Gac 
Méd Méx 2004;140:573–5.
 7. Lee HJ, Yoon SC, Ko JM, et al. Monochorionic dizygotic twins 
with discordant sex and confined blood chimerism. Eur J 
Pediatr 2015;173:1249–52.
Free Classified Ads and Announcements
Immunohematology will publish classified ads and announcements (SBB schools, meetings, symposia, etc.) without charge.
E-mail information to immuno@redcross.org or fax to (215) 451-2538
IMMUNOHEMATOLOGY, Volume 34, Number 4, 2018 157
 19. Shamshad GU, Ahmed S, Bhatti FA, Ali N. Mixed donor 
chimerism in non-malignant hematological diseases after 
allogeneic bone marrow transplantation. J Coll Physicians 
Surg Pak 2012;22:765–8.
 20. Penna LS, Silva FG, Salim PH, et al. Development of two 
multiplex PCR systems for the analysis of 14 X-chromosomal 
STR loci in a southern Brazilian population sample. Int J Legal 
Med 2012;126:327–30.
 21. McCann SR, Crampe M, Molloy K, Lawler M. Hematopoietic 
chimerism following stem cell transplantation. Transfus Apher 
Sci 2005;32:55–61. 
 22. Miura K, Niikawa N. Do monochorionic dizygotic twins 
increase after pregnancy by assisted reproductive technology? 
J Hum Genet 2005;50:1–6.
 23. Klipstein S, Regan M, Ryley DA, Goldman MB, Alper MM, 
Reindollar RH. One last chance for pregnancy: a review of 
2,705 in vitro fertilization cycles initiated in women age 40 
years and above. Fertil Steril 2005;84:435–45.
 24. Domingues AP, Dinis SR, Belo A, Couto D, Fonseca E, Moura 
P. Impact of induced pregnancies in the obstetrical outcome of 
twin pregnancies. Fertil Steril 2014;101:172–7.
 25. Daniels G. Human blood groups. 3rd ed. Oxford: Wiley 
Blackwell, 2013.
 26. Judd WJ, Johnson ST, Storry JR. Judd’s methods in 
immunohematology. 3rd ed. Bethesda, MD: American 
Association of Blood Banks, 2008.
 27. Pruss A, Heymann GA, Hell A, et al. Acute intravascular 
hemolysis after transfusion of a chimeric RBC unit. Transfusion 
2003;43:1449–51.
Blood chimerism in twins
Letícia Tavares, undergraduate student in Biomedicine, University 
of Vale do Itajaí, Itajaí, Brazil; Daiane Cobianchi da Costa, MSc, PhD, 
Supervisor of the Internship in Clinical Analyses, Coordinator of the 
Biomedicine Course at University of Vale do Itajaí, Itajaí, Brazil; Anna 
Paula de Borba Batschauer, MSc, PhD, Supervisor of the Internship 
in Clinical Analyses, Professor of Clinical Hematology, University of 
Vale do Itajaí, and Chief Technician, Batschauer Laboratory LTDA, 
Itajaí, Brazil; Luiz Fernando Job Jobim, MD, Professor of Internal 
Medicine, Federal University of Rio Grande do Sul, Rio Grande do 
Sul, Brazil, and Head, Immunology Service of the Clinics Hospital 
of Porto Alegre, Porto Alegre, Brazil; Gisele Menezes Ewald, MSc, 
Pharmacist and Biomedical Scientist, Immunology Service of the 
Clinics Hospital of Porto Alegre, Porto Alegre, Brazil; Carolina de 
Mello, degree in Biomedicine, graduate student in Laboratorial 
Hematology and Blood Bank Immunohematology, University 
Metropolitana de Blumenau, Blumenau, Brazil, and Biomedical 
Scientist, Transfusion Agency of Unimed Litoral Hospital, Itajaí, 
Brazil; Eduardo Samuel Alvarez Velazquez, degree in Biomedicine, 
Specialist in Clinical Pathology, University of Vale do Itajaí, 
Itajaí, Brazil, and Biomedical Scientist, Coordinator of Support 
Laboratories for Central de Exames Laboratories Network, Brazil; 
and Alexandre Geraldo (corresponding author), alexandregeraldo@
univali.br; MSc, Specialist in Hematology and Hemotherapy, 
Professor, Blood Bank at University of Vale do Itajaí, Consultant 
and Evaluator of the National Hemonetwork Qualification Program 
(PNQH)/General Coordination of Blood and Hemoderivatives of the 
Ministry of Health, Itajaí, Brazil.
The editorial staff of Immunohematology welcomes manuscripts 
pertaining to blood group serology and molecular genetics for 
consideration for publication. We are especially interested in 
review articles, case reports, papers on platelet and white cell 
serology, scientific articles covering original investigations or new 
blood group alleles, papers on molecular testing, and papers on 
new methods for use in the blood bank. To obtain instructions for 
submitting scientific articles, case reports, and review articles, 
see Instructions for Authors in every issue of Immunohematology 
or e-mail a request to immuno@redcross.org. Include fax and 
phone numbers and e-mail address with all manuscripts 
and correspondence. E-mail all manuscripts to immuno@
redcross.org.
Manuscripts
